VERU
VERU
NASDAQ · Pharmaceuticals

Veru Inc

$2.95
-0.04 (-1.34%)
As of Jun 21, 10:49 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,170.5% upside
Low Target $21.76
Average Target $37.48
High Target $51.92
Current Price $2.95
Current
$2.95
Target
$37.48
$21.76 $37.48 avg $51.92
Scenario Analysis
Bear Case
$21.76
637.6%
Low target
Base Case
$37.48
+1,170.5%
Avg target
Bull Case
$51.92
+1,660.0%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$7.33
-59.8% from high
52-Week Low
$2.05
+43.9% from low
Target vs 52W High
$37.48
+411.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%